Asset Turnover (Annual)

Asset Turnover: The amount of sales or revenues generated per dollar of assets. The Asset Turnover ratio is an indicator of the efficiency with which a company is deploying its assets. Calculated as: Total Revenues / Total Assets

Royalty Pharma PLC (RPRX) had Asset Turnover of 0.12 for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.26B
Net Income	$858.98M
Cost of Goods Sold	--
Gross Profit	$2.26B
Operating Expenses	$971.13M
Operating Income	$1.29B
Non-Operating Income/Expense	$38.37M
Pre-Tax Income	$1.33B
Normalized Pre-Tax Income	$1.18B
Income after Taxes	$1.33B
Income from Continuous Operations	$1.33B
Consolidated Net Income/Loss	$1.33B
Normalized Income after Taxes	$1.18B
EBIT	$1.29B
EBITDA	$1.31B
Weighted-Average Shares Outstanding (Basic)	448.19M
Weighted-Average Shares Outstanding (Diluted)	594.11M
Earnings per Share (EPS) (Basic)	$1.92
Earnings per Share (EPS) (Diluted)	$1.91
Balance Sheet Financials
Current Assets	$1.80B
Property, Plant, and Equipment	$15.13B
Long-Term Assets	$16.42B
Total Assets	$18.22B
Current Liabilities	$1.25B
Long-Term Debt	$6.61B
Long-Term Liabilities	$6.63B
Total Liabilities	$7.88B
Common Equity	$10.34B
Tangible Shareholders Equity	$10.34B
Shareholders Equity	$10.34B
Common Shares Outstanding	981.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.77B
Cash Flow from Investing Activities	$-2.68B
Cash Flow from Financial Activities	$361.14M
Beginning Cash	$477.01M
End Cash	$929.03M
Increase/Decrease in Cash	$452.02M
Stock-Based Compensation	$2.34M
Common Stock Dividends Paid	$-863.90M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.39
Debt to Equity Ratio	0.74
Gross Margin	100.00%
Operating Margin	57.10%
EBIT Margin	57.10%
EBITDA Margin	57.96%
Pre-Tax Profit Margin	58.79%
Profit Margin	37.95%
Free Cash Flow	$2.75B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	--
Receiveable Turnover	83.97
Days Sales in Receivables	4.35
Return on Equity	12.87%
Return on Tangible Equity	12.87%
Return on Assets	7.30%
Return on Investments	7.85%
Book Value Per Share	$10.54
Free Cash Flow per Share	$4.63
Operating Cash Flow per Share	$4.66

Data from Zacks Investment Research, Inc.